Pinnacle Wealth Planning Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Sell |
475
-14
| -3% | -$7.35K | 0.03% | 350 |
|
|
2025
Q1 | $310K | Buy |
489
+14
| +3% | +$8.88K | 0.05% | 252 |
|
|
2024
Q4 | $338K | Sell |
475
-137
| -22% | -$97.6K | 0.05% | 226 |
|
|
2024
Q3 | $643K | Hold |
612
| – | – | 0.09% | 150 |
|
|
2024
Q2 | $643K | Buy |
612
+1
| +0.2% | +$1.05K | 0.09% | 139 |
|
|
2024
Q1 | $588K | Hold |
611
| – | – | 0.09% | 155 |
|
|
2023
Q4 | $537K | Sell |
611
-2
| -0.3% | -$1.76K | 0.08% | 166 |
|
|
2023
Q3 | $504K | Sell |
613
-3
| -0.5% | -$2.47K | 0.08% | 160 |
|
|
2023
Q2 | $443K | Sell |
616
-9
| -1% | -$6.47K | 0.07% | 187 |
|
|
2023
Q1 | $514K | Buy |
625
+2
| +0.3% | +$1.64K | 0.09% | 171 |
|
|
2022
Q4 | $449K | Buy |
623
+12
| +2% | +$8.66K | 0.08% | 186 |
|
|
2022
Q3 | $421K | Buy |
611
+30
| +5% | +$20.7K | 0.08% | 170 |
|
|
2022
Q2 | $343K | Sell |
581
-13
| -2% | -$7.68K | 0.06% | 215 |
|
|
2022
Q1 | $415K | Buy |
594
+165
| +38% | +$115K | 0.08% | 198 |
|
|
2021
Q4 | $271K | Buy |
429
+17
| +4% | +$10.7K | 0.05% | 278 |
|
|
2021
Q3 | $249K | Buy |
412
+16
| +4% | +$9.67K | 0.06% | 277 |
|
|
2021
Q2 | $221K | Buy |
+396
| New | +$221K | 0.05% | 291 |
|
|
2021
Q1 | – | Sell |
-270
| Closed | -$130K | – | 1581 |
|
|
2020
Q4 | $130K | Buy |
+270
| New | +$130K | 0.03% | 381 |
|